Vol 33 No 12

Targeted mineral supplementation has the potential to augment treatment response and yield improvement in clinical symptoms.

Integrative psychiatry helps us push deeper into the testing of metabolic, gut, and brain features, which seems more fitting, given our role as physicians.

These methods facilitate deep rest, help reset circadian rhythm, and release endogenous opioids and cannabinoids that help reduce anxiety and enhance a sense of well-being for people with PTSD.

Potential benefits and benign safety profile of omega-3s indicate a promising intervention.

Can't keep up with the literature? Here's some help.

Here: a look at the associations between negative psychological states and CV health, physiologic and health behavior mechanisms, and ways to diagnose and treat depression and anxiety disorders.

With antipsychotics, my once-brilliant child can again speak, write, read, and maintain hygiene and has regained motor functioning.

As our understanding of the brain and new technologies have rapidly evolved, such an extensive text on psychiatric ethics is clearly timely.

Here's a case that illustrates the potential for alprazolam to create a dementia-like appearance-not to mention a premature aging of the patient.

What are the limitations and advantages of biomedicine and Asian medicine? When is it more beneficial to use one or the other? Guidelines for combining the two?

Here’s a very unscientific survey of this year’s most meaningful issues is psychiatry. Quite a year.

How do meaning, memory, emotions and, especially, human suffering arise from the brain?

Bolted to the bedroom loft, twenty feet high with lacquered sides and honey colored risers polished with pine-scented wax-these are the rungs I climb to the feather bed, candle, and bottle of red wine...

Since ancient times, doctors have shown a good deal of interest in identifying seasonal patterns in the incidence of symptoms and disease. Could the holiday blues be a myth?

Be cautious: not all obsessive thinking is OCD.

Two recent clinical trials of opioid medication for depression and suicidality highlight the role of brain opioid systems in depression.

A recent meta-analysis shows this adjunctive agent reduces residual symptoms of psychopathology as well as body weight.